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Hybrid Self-Assembled Gel Beads for Tuneable
pH-Controlled Rosuvastatin Delivery
Carmen C. Piras,[a] Anna K. Patterson,[a] and David K. Smith*[a]
Abstract: This article describes the fabrication of new pH-
responsive hybrid gel beads combining the polymer gelator
calcium alginate with two different low-molecular-weight
gelators (LMWGs) based on 1,3 : 2,4-dibenzylidene-d-sorbitol:
pH-responsive DBS-COOH and thermally responsive DBS-
CONHNH2, thus clearly demonstrating that different classes of
LMWG can be fabricated into gel beads by using this
approach. We also demonstrate that self-assembled multi-
component gel beads can be formed by using different
combinations of these gelators. The different gel bead
formulations exhibit different responsiveness – the DBS-
COOH network can disassemble within those beads in which
it is present upon raising the pH. To exemplify preliminary
data for a potential application for these hybrid gel beads, we
explored aspects of the delivery of the lipid-lowering active
pharmaceutical ingredient (API) rosuvastatin. The release
profile of this statin from the hybrid gel beads is pH-
dependent, with greater release at pH 7.4 than at pH 4.0 –
primary control of this process results from the pKa of the API.
The extent of pH-mediated API release is also significantly
further modified according to gel bead composition. The
DBS-COOH/alginate beads show rapid, highly effective drug
release at pH 7.4, whereas the three-component DBS-COOH/
DBS-CONHNH2/alginate system shows controlled slow release
of the API under the same conditions. These initial results
indicate that such gel beads constitute a promising, versatile
and easily tuned platform suitable for further development
for controlled drug-delivery applications.
Introduction
Hydrogels self-assembled from low-molecular-weight gelators
(LMWGs) are versatile, multifunctional materials of intense
current interest due to their responsive and tuneable nature.[1]
In particular, there has been considerable recent development
of such materials for uses in biomedicine, drug delivery and
tissue regeneration.[2] In drug delivery, hydrogels can potentially
release active pharmaceutical ingredients (API) at a target site
in response to specific stimuli, such as pH changes. Being
robust, easy-to-prepare and handle, hydrogels formed from
polymer gelators (PGs) have been widely employed as drug
delivery materials.[3] However, LMWGs are gaining increasing
attention as an alternative to polymers for next-generation
therapeutic carriers, as a result of advantages offered by their
synthetic programmability, biodegradability and high degree of
responsiveness to external stimuli.[2]
Compared to polymeric materials, hydrogels assembled
from LMWGs are often soft and difficult to handle without
breakage. As such, LMWGs have often been considered as
particularly attractive candidates for transdermal or subcuta-
neous injection delivery modes.[4] However, there is increasing
interest in the development of more robust shaped and
patterned formulations of LMWGs for a range of applications.[5]
The formulation of shaped and structured LMWG-based
systems, such as capsules or beads, remains a fascinating
challenge.[6] Such systems have potential both in oral drug
delivery for controlled release in the GI tract, or in the
development of implantable or injectable drug delivery depots,
which could achieve either controlled local API delivery, or slow
longer-term systemic API release.
The combination of LMWGs with PGs to obtain hybrid gels
that display greater robustness, whilst maintaining responsive-
ness to external stimuli is a known strategy to expand the range
of potential applications of such materials.[7] In this regard, we




natural polysaccharide PG calcium alginate (Figure 1).[8] As a
result of the orthogonal gelation mechanisms, this combination
could be formulated into core-shell gel beads. By loading these
gel beads with metal nanoparticles, we demonstrated their
potential both in catalysis[8a] and antibacterial[8b] applications.
We have also recently used this approach to generate smaller
injectable microgel beads with diameters of about 800 nm, and
shown that such microgels can release bioactive agents to
enhance tissue growth.[9] With the goal of controlled drug
delivery, we have previously been interested in multicompo-
nent hydrogels.[10] As a result, we decided to develop gel beads
with stimulus responsiveness. We reasoned that incorporating
the pH-responsive gelator DBS-COOH, and drawing on our
previous experience of combining it with DBS-CONHNH2,
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could be a way of achieving this. Importantly, both of these
LMWGs have been previously demonstrated to be biocompat-
ible as part of multicomponent systems used for tissue
growth.[12] We herein describe the preparation of pH-responsive
self-assembled gel beads obtained by combining these LMWGs
with calcium alginate, the first time a pH-responsive LMWG has
been combined with an alginate PG, and subsequently explore,
in a preliminary way, their potential for the release of the lipid-
lowering medication rosuvastatin.[13]
Statins are key cholesterol-lowering medications widely
prescribed to the general public as a preventative against
adverse events such as heart attacks and strokes.[12] As one
example, rosuvastatin (Figure 1) is usually administered orally as
a tablet in a 5–40 mg daily dose and is mainly absorbed from
the intestine (pH 8.0).[14] Statins have also been suggested to
have positive effects on bone growth[15] and are being
particularly explored in the field of dentistry for the treatment
of periodontitis.[16] There has therefore been considerable
interest in the local delivery of statins, including their
formulation with simple polymer gels.[17]
Given the need for both local and systemic delivery of this
important class of drug, there is considerable ongoing interest
in alternative statin formulations. For example, enhanced GI
delivery may better deliver some of these poorly soluble drugs,
while injectable or implantable delivery systems would also be
of value either in local, or long-term statin delivery. It is worth
noting that the relatively low daily dose of drugs (<40 mg/day)
makes them particularly well suited to this approach, as it
facilitates drug loading into the gel. Amongst this class of drug,
we were particularly interested in rosuvastatin as it is acid-
functionalised, and as demonstrated in our previous work with
the painkiller anti-inflammatory drug naproxen,[10] we reasoned
this should introduce a degree of inherent pH control into the
delivery process. To the best of our knowledge, this is the first




DBS-COOH was synthesized in good yield using our previously
reported method.[18] This LMWG forms hydrogels at low
concentrations (0.2–0.3% w/v) in a mildly acidic pH regime
below its pKa value of 5.4. Alginate is a commercially available
PG that forms hydrogels when combined with bivalent cations,
such as Ca2+.[19] Since these two gelation triggers can be
temporally controlled, we decided to fabricate two-component
DBS-COOH/alginate hydrogels by inducing the self-assembly of
the PG first, followed by slower pH-induced assembly of the
LMWG. To form gel beads, we therefore combined a basic DBS-
COOH aqueous solution (0.3% w/v) with sodium alginate (0.5%
w/v). The resulting mixture was added dropwise (20 μL drops)
to a CaCl2 solution (5.0% w/v), which had been acidified by
addition of HCl to give an 0.01 M concentration of acid. Small
gel beads were immediately formed (Figure 2a and Figure S13
in the Supporting Information). The gel beads were initially
transparent and then turned more translucent, which would
suggest a process in which, as predicted, the PG assembled
first, and then the LMWG assembled. Indeed, in its own right,
when treated in sample vials in this way, the LMWG forms a
translucent self-assembled gel. These gel beads had diameters
of 2.8–3.3 mm (Figure 2a, b and d), which relates to the 20 μL
drop volume. Beads with different diameters could be obtained
by adding different volumes to the cross-linker solution (Fig-
ure S13). Importantly, this is the first time a pH-responsive
LMWG has been combined with calcium alginate, and demon-
strates the versatility of the alginate LMWG stabilization
methodology previously developed in our labs.[8] In addition to
forming gel beads, we also formed hybrid gels in vials for
detailed characterisation and control experiments – these
systems are described fully in the Supporting Information.
As gelation of the two networks depended on both the H+
and Ca2+ ions in the acidic CaCl2 solution, we reasoned that the
two self-assembled networks would be woven within the whole
Figure 1. Chemical structures of the LMWGs DBS-COOH and DBS-CONHNH2,
the PG component alginic acid and the statin drug rosuvastatin.
Figure 2. a) DBS-COOH/alginate gel beads. SEM images of b) a whole gel
bead and c) the gel bead surface. d) Optical microscopy of a DBS-COOH/
alginate gel bead cross-section embedded into resin and stained with
toluidine blue. e) and f) SEM images of DBS-COOH/alginate gel bead cross-
section at different magnifications.
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gel bead volume, rather than forming core-shell structures, as
previously described for the DBS-CONHNH2/alginate gel beads.
This hypothesis was confirmed by optical microscopy of the gel
beads cut in half, embedded in resin and dyed with toluidine
blue, which showed a uniform hybrid gel bead cross-section
comparable to that of beads formed by calcium alginate alone
(Figures 2d and S14). SEM provided an insight into the fibrous
structures of the surface and cross-section of the gel beads
(Figure 2c, e and f). The DBS-COOH/alginate gel bead surface
appeared to be wrinkled and densely packed (Figures 2c, S22
and S23). The cross-section image indicated an extended
network throughout the gel bead, confirming that the gelators
were in their self-assembled state inside the bead (Figures 2e, f
and S25). We saw no evidence by SEM of precipitated,
unstructured material within the beads, consistent with the
view that the LMWG was indeed self-assembling under
controlled conditions during bead fabrication.
To further confirm the self-assembly of DBS-COOH within
the gel bead, we performed a simple 1H NMR experiment. We
prepared ten DBS-COOH/alginate beads using D2O instead of
water and transferred them into a NMR tube containing D2O
(0.5 mL) and MeCN (3.0 μL) as an internal standard (Section S3.1
in the Supporting Information, ). If the DBS-COOH was not in its
self-assembled state, the percentage of the mobile components
could be calculated by comparison of the integral peaks of the
DBS-COOH aromatic peaks (δ=7.55 and 7.95) to that of the
methyl group of acetonitrile (δ=2.09 ppm). The 1H NMR
spectrum showed no signals for either DBS-COOH or alginate
(Figure S1), thus confirming that both gelators were fully
immobilised within the gel beads. Combined with the results
from imaging, this clearly indicates that controlled self-assembly
of the LMWG occurs.
The exact amount of DBS-COOH incorporated into each gel
bead was then quantified, also by 1H NMR (Section S3.2). The
DBS-COOH/alginate gel beads were prepared in water (1 mL)
using 0.3% w/v DBS-COOH (6.72 μmol) and 0.5% w/v alginate.
Ten gel beads were isolated and dried under vacuum. The
resulting solid was dissolved in [D6]DMSO, which dissolved the
DBS-COOH, but not the alginate, and a known volume of MeCN
(3.0 μL) was added as an internal standard. The concentration
of DBS-COOH was calculated by comparison of the integrals of
the DBS-COOH aromatic peaks (δ=7.55 and 7.95) to that of the
methyl group of acetonitrile (δ=2.09 ppm). The experiment
showed that each gel bead incorporated 0.13 μmol of DBS-
COOH (Figure S2). Considering that the gel beads were
prepared using a 20 μL volume, in principle 50 gel beads could
be obtained from the 1 mL of solution used. If each gel bead
contained 0.13 μmol of DBS-COOH, as demonstrated by NMR
spectroscopy, 50 gel beads would contain a total of 6.34 μmol
of DBS-COOH, which corresponds to about 94% of the DBS-
COOH initially loaded. This reproducible experiment therefore
confirms the efficiency of the fabrication method with almost
all of the added DBS-COOH ending up assembled within the gel
beads.
To verify the responsiveness of the DBS-COOH/alginate gel
beads to pH, we performed a further 1H NMR study. Ten gel
beads were prepared in D2O and transferred into a NMR tube.
D2O (0.5 mL), NaOD (0.5 M, 60 μL, ca. 23 equiv.) and the internal
standard MeCN (3.0 μL) were then added (Section S3.3). The
sample was left undisturbed overnight and the 1H NMR
spectrum was recorded at 30 min intervals. The percentage of
mobile components was calculated by comparison of the
integrals of the aromatic peaks of the DBS-COOH to that of
acetonitrile (Figure S3). As the pH rises to about 10.8–11.6, the
DBS-COOH network is disrupted and disassembles (Figure S4).
This process occurs rapidly, and indeed after just 30 minutes,
about 40% of the DBS-COOH incorporated into each gel bead
becomes mobile. On monitoring for extended periods this does
not rise any further, indicating the rapid response of these gel
beads to pH change. It is possible that the remaining DBS-
COOH (60%) interacts with the calcium alginate network,
preventing its full mobility (see Discussion below).
The supramolecular interactions between the LMWG and
the PG within the self-assembled gel beads were investigated
by IR spectroscopy. A clear shift of the O H stretch of alginate
to lower wavenumber is visible in the presence of the DBS-
COOH network for the hybrid gel (Figure S10). The C=O stretch
of DBS-COOH also shifted to lower frequencies in the presence
of increasing alginate concentrations (Figure S10). These shifts
suggest some supramolecular interactions between the two gel
networks in the hybrid gel bead, and are similar to what was
observed for the corresponding interpenetrated gels (Fig-
ure S9). This might also help explain why about 50% of the
DBS-COOH did not become mobile when the pH of the system
was raised. We suggest that some of the DBS-COOH may
remain associated with the calcium alginate network under
basic conditions – it is plausible that the carboxylate ion will
interact with the divalent calcium ions present within the
system.
We performed parallel plate rheology on equivalent two-
component gels formed in vials, to demonstrate that the
presence of the calcium alginate network enhances the
mechanical strength and stiffness of these gels (Table S2,
Figures S26, S32–S34 and S36). Specifically, the elastic modulus
(G’) of the DBS-COOH gel (0.4% w/v) progressively increases
from 360 Pa to 905, 2660, 5300 and 12000 Pa with increasing
alginate loadings of 0.1, 0.3, 0.5 and 1.0% w/v, respectively.
In summary, we therefore confirmed that these two gelators
form co-assembled gel beads with the interwoven networks
behaving in similar ways to within a bulk gel, and that the DBS-
COOH network could be individually addressed within these
gels by raising the pH.
DBS-CONHNH2/alginate gel beads
Beads based on DBS-CONHNH2 and calcium alginate were
prepared and characterised as previously described,[8] in which
a hot aqueous solution of DBS-CONHNH2 is added dropwise
into a CaCl2 solution. This yields beads with a core-shell
structure. All characterisation of these beads was in-line with
our previous work (see also Figures S16 and S37).
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DBS-COOH/DBS-CONHNH2/alginate gel beads
We then combined all three gelators to obtain multicomponent
gel beads – this level of complexity in LMWG gel beads has not
previously been achieved and it is therefore important to
carefully characterise this multicomponent system.[20] We com-
bined the procedures for the two different types of gel bead,
and mixed a basic DBS-COOH aqueous solution (0.3% w/v) with
DBS-CONHNH2 (0.3% w/v) and sodium alginate (0.5% w/v). The
resulting suspension was sonicated to help the dispersion of
the solid particles and then heated until complete dissolution
of the DBS-CONHNH2. The hot solution was then added
dropwise (20 μL drops) to a CaCl2 solution (5.0% w/v), acidified
with HCl at a concentration of 0.01 M. Small gel beads were
immediately formed on simultaneous self-assembly of the three
gel networks (Figure 3a). As expected based on the 20 μL drop
volume, they had diameters of 3.0–3.5 mm (Figure 3a, b and d).
The diameter could be tuned by changing the volume added to
the crosslinker solution.
We reasoned that these gel beads may have a core-shell
structure as a result of the use of a hot solution, similar to DBS-
CONHNH2/alginate beads. We suggest the core may contain the
self-assembled DBS-CONHNH2/DBS-COOH, wrapped in a DBS-
COOH/alginate shell. The hypothesis of a core-shell nature was
confirmed this by optical microscopy of a cross-section of the
gel beads embedded in resin and stained with blue toluidine
(Figures 3d and S17). The surface and cross-section of the gel
beads were analysed by SEM microscopy which showed that
the bead surface was wrinkled (Figure 3c and S24) and
indicated the presence of a fibrous network inside the beads
(Figure 3e, f and S25), suggesting that the gelators were
incorporated into the gel beads in their self-assembled state.
Once again there was no evidence of precipitated, unstructured
LMWG material within the beads.
The self-assembly of all three gelators was further confirmed
by a simple 1H NMR experiment performed on ten gel beads
prepared in D2O, using MeCN as an internal standard, in the
same way as described above for the DBS-COOH/alginate gel
beads (Section S3.4). The absence of signals in the spectrum
demonstrated that the three gelators were in their self-
assembled state (Figure S4). The amount of DBS-COOH and
DBS-CONHNH2 incorporated into the multicomponent gel
beads was quantified by 1H NMR, once again as described
above for the DBS-COOH/alginate gel beads (Section S3.5). Ten
DBS-COOH/DBS-CONHNH2/alginate gel beads were dried under
vacuum and the solid was dissolved in [D6]DMSO. By comparing
the integrals of the aromatic protons of DBS-COOH and DBS-
CONHNH2 (DBS-COOH aromatic peak δ=7.95 and DBS-
CONHNH2 aromatic peak δ =7.82) to that of the methyl group
of the internal standard MeCN (δ=2.09), we were able to
calculate that 0.13 μmol of DBS-COOH and 0.11 μmol of DBS-
CONHNH2 were incorporated into each gel bead (Figure S6).
This corresponds to >90% of each of the loaded LMWGs,
confirming the efficiency of the preparation method.
We performed parallel plate rheology on equivalent two-
component gels formed in vials, to demonstrate that the
presence of the calcium alginate network enhances the
mechanical strength and stiffness (Table S2, Figures S39–S42,
S44). Specifically, the DBS-COOH/DBS-CONHNH2 gel prepared
using a 0.3% w/v concentration of the two LMWGs had an
elastic modulus of 5410 Pa. In the presence of increasing
alginate concentrations (0.1, 0.3, 0.5 and 1.0% w/v), the G’ value
increased to 6950, 15200, 19000 and 37300 Pa, respectively.
These gels were stiffer than the DBS-COOH/DBS-CONHNH2 gel,
reflecting the additional stiffness provided by the calcium
alginate. Furthermore, they were significantly stiffer than the
DBS-COOH/alginate gel described above, indicating that this
three-component gel system assembles a denser, more inter-
active network (see below).
To verify the responsiveness of these three-component
DBS-COOH/DBS-CONHNH2/alginate gel beads to pH, we per-
formed another 1H NMR study, as previously described for the
two-component DBS-COOH/alginate system. Ten gel beads
were prepared in D2O and transferred into a NMR tube. D2O
(0.5 μL), NaOD (0.5 M, 60 μL, ca. 23 equiv.) and the internal
standard MeCN (3.0 μL) were then added (Section S3.6) giving a
pH value of 10.8–11.6. The sample was left undisturbed
overnight and the 1H NMR spectrum was then recorded every
30 min. The percentage of mobile components was calculated
by comparison of the integrals of the aromatic peaks of the two
LMWGs to that of acetonitrile (Figures S7 and S8). It was found
that about 50% of the DBS-COOH was rapidly mobilised in the
first 30 minutes within the beads. This figure rose to about 60%
after 2.5 h and then remained approximately constant. This
treatment also caused a minor effect on the DBS-CONHNH2
with about 25% of the DBS-CONHNH2 being mobilised in the
first 30 min, rising to 30% after 1 h, and then remaining
approximately constant. This may reflect disruption of the
supramolecular interactions between the two LMWGs within
the gel beads-it is known that when these gelators are co-
assembled there are some interactions between the sequen-
tially formed gel networks.[11]
Furthermore, we used rheology to investigate the pH-
responsiveness of DBS-COOH/DBS-CONHNH2/alginate gels in
vials, and demonstrated that the G’ value dropped from 37300
Figure 3. a) DBS-COOH/DBS-CONHNH2/alginate gel beads. SEM images of b)
a whole gel bead and c) the gel bead surface. d) Optical microscopy of a
DBS-COOH/DBS-CONHNH2/alginate gel bead cross-section embedded into
resin and stained with toluidine blue. e) and f) SEM images of DBS-COOH/
DBS-CONHNH2/alginate gel bead cross-sections.
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to 28300 Pa after exposure to a small amount of aqueous
NaOH for 24 h (Figure S36), raising the pH to 10.8–11.6. After
further exposure to glucono-δ-lactone as a proton source
(lowering the pH to ca. 4.0) the G’ value increased again to
34500 Pa (Figure S37), indicating that not only can the DBS-
COOH network be disassembled and re-assembled in these
gels, but that this process has a direct impact on the rheological
performance of the hybrid gels, with the stiffness decreasing as
the DBS-COOH network disassembles and increasing as it
reassembles again.
Applications of gel beads in rosuvastatin release
Taking into account the pH-responsiveness of these gel bead
formulations, we decided to focus on drug delivery to exemplify
a potential application. Rosuvastatin displays a characteristic UV
absorbance peak at 251 nm, therefore drug release from the
gels in different pH buffers could be monitored by UV-vis
spectroscopy at regular time intervals. We selected two differ-
ent release media: a neutral pH buffer, 10 mM Tris·HCl/150 mM
NaCl (pH 7.4), and a mildly acidic pH buffer, 0.1 M sodium
acetate (pH 4.0). To make sure that the observed UV signal was
produced by the rosuvastatin released from the gels rather than
disruption of the self-assembled gel networks, negative control
experiments on gels without rosuvastatin were carried out at
the same time and the collected data were normalized
accordingly. In general, the amount of LMWG released from the
gel beads was only very small (see the Supporting Information).
We considered loading the drug during gel bead fabrica-
tion, and note that in some cases this may actually be the most
appropriate and desirable approach. However, we were con-
cerned that in our workflow for bead preparation, the drug may
simply leach from the beads during stirring in the large volume
aqueous Ca2+/H+ bath. This would lead to difficulties quantify-
ing the amount of drug incorporated into the beads. As such,
for this initial study, we decided to load the drug after the
formation of the gel beads using a “soaking” methodology,
which allowed effective quantification of drug loading. We
anticipated that this loading method initially relies on simple
diffusion, but that specific interactions between the drug and
the gel networks would then have the chance to establish
themselves as loading progressed.
To understand the loading process further, the gels in vials
were loaded with rosuvastatin in the same way, and then
studied using parallel plate rheology. As a general rule, the
rosuvastatin-loaded gels were broadly similar to those with no
API present (Table S2, Figures S30, S35, S38 and S43). This
indicates that the presence of the API does not significantly
impact on the assembled gel network. Analysing the data in
more detail suggested that in the presence of the API, most of
the gels became slightly less stiff. The one exception was DBS-
CONHNH2/alginate loaded with rosuvastatin, where the stiffness
increased slightly – this might reflect noncovalent interactions
between the acid-functionalised rosuvastatin and the DBS-
CONHNH2 gel network (see Discussion) leading to the slight
network stiffening.
All gel beads used in the drug release studies were
therefore prepared as described above and subsequently
loaded with rosuvastatin calcium by soaking in an aqueous
solution of the drug (0.11 mM, 4 mL). After 24 h, the drug
solution was removed and used to quantify the exact amount
of drug incorporated into each gel by UV-vis spectroscopy (ca.
0.22 μmol/gel bead). The release buffer (6 mL) was then added
to the gel samples, which were then incubated at 37 °C for 24 h.
Drug release was then monitored at regular time intervals by
UV-vis spectroscopy (251 nm).
Initially, we explored the release of rosuvastatin calcium
into 10 mM Tris ·HCl/150 mM NaCl at pH 7.4 (Figure 4, top,
Table S4). For the DBS-COOH/alginate gel beads, about 85%
release was achieved after 24 h, with release being mostly
complete (80%) after about 2 h. Leaving the system for 1 week
eventually gave 85–90% release. In the DBS-CONHNH2/alginate
Figure 4. Rosuvastatin calcium % released in top: 10 mM Tris ·HCl/150 mM
NaCl (pH 7.4) from gel beads and bottom: in 0.1 M sodium acetate (pH 4.0)
from gel beads.
Chemistry—A European Journal 
Full Paper
doi.org/10.1002/chem.202101405
13207Chem. Eur. J. 2021, 27, 13203–13210 www.chemeurj.org © 2021 The Authors. Chemistry - A European Journal published by Wiley-VCH GmbH
gel beads release was about 55–60% after 24 h (65% after
1 week), and for calcium alginate beads was about 40% after
24 h (45% after 1 week). For the three-component DBS-COOH/
DBS-CONHNH2/alginate system, API release was much slower,
and only reached a maximum of 30% after 24 h. Over a week,
the API release from these three-component beads rose to
about 45%.
At pH 4.0, in sodium acetate buffer, the drug release profiles
were significantly different (Figure 4, bottom, Table S6). For the
DBS-COOH/alginate gel beads, the amount of drug released
was less than at pH 7.4, only being about 45–50%. In the DBS-
CONHNH2/alginate gel beads this value was only about 30%,
very similar to the calcium alginate beads. For the three-
component DBS-COOH/DBS-CONHNH2/alginate system, the
drug release was now very much slower, and only reached a
maximum of 7% after 24 h.
We also considered drug release at pH 1.2 (Table S7,
Figure S48), which is a good simulation of conditions in the
stomach, relevant for oral delivery via the GI tract. In this case,
we found that under these conditions, the DBS-CONHNH2 gel
network broke down, presumably as a result of protonation of
the NH2 group. There is also the possibility of acetal hydrolysis
leading to degradation of the gelator, however, DBS-COOH was
less affected, so we suggest this is a slower process. The release
from gels containing DBS-CONHNH2 was therefore much higher
under these conditions than at pH 4, reaching 60%+ , presum-
ably as a result of partial gel bead breakdown. For the DBS-
COOH/alginate beads, the release level was about 40% after
24 h, slightly less than at pH 4.0. For calcium alginate beads, the
release was only about 20% at pH 1.2, once again slightly lower
than at pH 4.0.
In order to interpret these results fully, it first needs to be
considered that rosuvastatin is a weak acid with a pKa of 4.6.
[21]
Taking into consideration the Henderson-Hasselbach equation,
this means that at pH 7.4, >99% of the drug is in its ionised
form, which has the highest solubility in water and can
therefore be more easily released from the gels. Conversely, at
pH 4.0, the drug will be largely protonated, with lower solubility
and release of the drug will therefore be more challenging. This
inherent physicochemical property of rosuvastatin is reflected
in the data, which indicates significantly greater API release for
all gels at pH 7.4 than at pH 4.0. We consider the pKa to be the
primary factor controlling the release of the API in this case.
However, on analysing the data in more detail, it is clear that
the formulation of the gel bead also impacts significantly on
the specifics of API release (see Discussion) and we consider
this to be an important secondary factor controlling drug
release in this case.
Laid on top of this primary pH effect, there are also clear
effects of gel bead composition on the release of rosuvastatin
(Figure 5). It is evident for example, that the % release increases
with pH, but that this effect is less significant for alginate alone
than for those beads containing the LMWGs. This indicates that
the gel bead composition modifies the pH effect on API release,
particularly between pH 4.0 and 7.4. Furthermore, the precise
choice of LMWG directly affects the amount of API released,
with more release when using DBS-COOH than DBS-CONHNH2,
which in turn has more release than the three-component
system containing both LMWGs. This clearly demonstrates that
the chemical nature of the gel beads, as well as the pKa of the
API, are playing active roles in controlling API release.
In terms of comparing the performance of the different gel
beads, it is firstly worth noting that the calcium alginate system
on its own limits the release of rosuvastatin (this was also
observed for release of the API from samples made in vials, so it
is not just a function of the bead structure; Table S3, Fig-
ure S47). We suggest this limited API release is the result of
interactions between rosuvastatin and the calcium alginate
network, likely between the carboxylic acid of rosuvastatin and
the divalent calcium ions in the PG. Interestingly, however,
when DBS-COOH is also present, there is significantly greater
release of rosuvastatin, especially at pH 7.4 than at lower pH
values. We suggest that as the pH rises, and the DBS-COOH
deprotonates causing the self-assembled network to disassem-
ble, the resulting LMWG carboxylate ion can itself interact with
the calcium alginate PG network (this would also explain why
not all of the DBS-COOH is released into free solution from the
gel in basic conditions, as described above and determined
using NMR methods). This competitive effect of the DBS-COOH
would enable greater release of rosuvastatin from the gel. In
this way, we suggest that the pH-responsiveness of the DBS-
COOH gel beads triggers enhanced release of the API.
It is known that DBS-CONHNH2 can specifically interact with
acidic drugs at low pH values.[10] A similar effect seems to be
operational here, with just 30% rosuvastatin release from the
DBS-CONHNH2/alginate system at pH 4.0, but 60% release at
pH 7.4. In this case, on raising the pH from 4.0 to 7.4,
noncovalent interactions between the DBS-CONHNH2 gel net-
work and rosuvastatin are being switched off as the drug gets
deprotonated. It is possible that the presence of the alginate
network still slightly limits the release of the drug at the higher
pH value by forming interactions with the API, this effect would
be magnified by the core shell structure of these beads because
the shell is based on calcium alginate.
For the three-component system, drug release is low under
both pH conditions, but especially so at pH 4.0. We suggest that
Figure 5. Summary of the effect of pH on % rosuvastatin release after 24 h
from gel beads of different composition. Data for gel beads containing DBS-
CONHNH2 at pH 1.2 are omitted as the beads were not fully stable under
these conditions.
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the pH differences are primarily largely induced by the
ionisation state of the rosuvastatin with greater release above
its pKa value. There will be a significant degree of interaction of
the drug with DBS-CONHNH2 below the pKa value when the
drug is protonated – this is potentially more marked than in the
system that only had DBS-CONHNH2/alginate, because the DBS-
COOH/DBS-CONHNH2/alginate three-component system is
formed in the presence of an acid, which may further lower the
internal pH of the gel bead, hence ensuring the rosuvastatin is
fully protonated. Even at pH 7.4, drug release remains some-
what limited in this three-component system. We note that in
addition to the more densely packed network and the core-
shell structure, interactions between DBS-CONHNH2 and DBS-
COOH (see above) mean that rosuvastatin can potentially also
still interact with the calcium alginate network. As well as
restricting the amount of API released, the release is also
kinetically very significantly slower: after 2 h only about 17%
API has been released, rising to 30% after 24 h and 45% after
3 days. This suggests that this system only releases the drug
slowly over time, possibly as a result of the denser, more
interactive, multicomponent network.
Conclusion
To conclude, we have fabricated pH-responsive self-assembled
gel beads by combining the polymer gelator calcium alginate
with the LMWGs DBS-COOH and DBS-CONHNH2, thus demon-
strating for the first time that a range of LMWGs, assembled via
different triggers, can be incorporated into gel beads by using
an alginate-based methodology. The polymer gelator enhances
the thermal stability and the mechanical properties of the
hybrid gels compared to the gels formed by the individual
components. The rheological performance varies depending on
the percentage of alginate incorporated, thereby giving gels
with a range of stiffnesses. We demonstrated that the DBS-
COOH network could be selectively disassembled in response
to pH, thus making these responsive gels potentially appealing
for drug-delivery applications.
In particular, we explored the release of the statin drug
rosuvastatin calcium, a lipid-lowering medication, in different
pH buffers. The release of rosuvastatin calcium is pH-dependent
and also depends on the composition of the gel bead.
Specifically, the presence of pH-responsive DBS-COOH enhances
delivery, whereas interactive DBS-CONHNH2 appears to limit
drug release, especially at acidic pH values and in the three-
component system. By tuning the composition of the gel beads,
we are able to either achieve rapid, almost complete release of
the API with the DBS-COOH/alginate beads, or alternatively
much slower, more controlled release over a multi-day time-
scale with the three-component gel bead system (Figure 6).
Such different profiles of drug release might, in the future,
be useful in different settings, with the former having potential
for applications in bone regrowth or dentistry, which require
rapid local release, but the latter being potentially useful for the
development of slow systemic drug-release applications for the
treatment of hypercholesterolemia over the longer term. We
therefore believe that our multicomponent gel beads could
potentially be further developed as tuneable dosage systems
for a variety of drugs, and could be a versatile platform for
drug-delivery applications. In this regard, it will be important to
optimise drug loading into such gel beads – in the study here,
we have focused on ensuring rosuvastatin is soluble at all times
to facilitate analysis. As such, the total amounts of API released
are somewhat below the therapeutic level. In future work, we
intend to maximise the loading of the drug into the beads,
even if in solid form. This should provide greater potential for
the release of therapeutic levels of the drug over extended
timescales. This will be an important next step in preclinical
development. It will also be necessary to consider carefully how
the delivery vehicle can best be administered. We note that,
with approximately 3 mm diameter, the beads reported here
are too large for most local/systemic applications, which would
better make use of injection as a delivery mode. However, we
have recently demonstrated the potential to develop injectable
microgels from this type of system,[9] and we therefore reason
that statin-loaded injectable microgel beads might be achiev-
able. Such systems would be potentially transformative in
injectable local and systemic delivery, and work towards this
goal is currently a key target in our laboratory.
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